Chief Scientific Officer, Psylo
| Role | Organisation | Sources |
|---|---|---|
| Chief Scientific Officer | Psylo | Startup Daily (Tue 4 Jun 2024), Startup Daily (Thu 27 Oct 2022), Startup Daily (Wed 6 Oct 2021), Startup Daily (Fri 1 Oct 2021) |
| Team Leader in Medicinal Chemistry (former) | The University of Sydney | Startup Daily (Tue 4 Jun 2024), Startup Daily (Fri 1 Oct 2021) |
| Team Leader in Medicinal Chemistry (former) | Brain and Mind Centre | Startup Daily |
Stories naming Dr Samuel Banister. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Psylo, a Sydney maker of psychedelic therapies, has landed a US$8 million seed round led by Tenmile while moving to the US; earlier raises in 2022 and 2021 are recalled.
Sydney psychedelic biotech Psylo has banked a $5 million seed round led by CSIRO's Main Sequence Ventures, its second raise since emerging from Startmate, to advance a fast-acting psilocybin therapy toward clinical trials.
Startup Daily lists the 19 Australian and New Zealand startups in Startmate's largest-ever Winter21 cohort pitching at Demo Day, including a climate stream backed by Mike Cannon-Brookes through Grok Ventures.
Sydney psychedelic biotech Psylo has raised $1.1 million in a round led by Possible Ventures, with angel Daniel Petre also backing it, to develop shorter-acting psilocybin-inspired mental health medicines.